N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation. CommentaryPRICKETT, Timothy C. R; KAAJA, Risto J; NICHOLLS, M. Gary et al.Clinical science (1979). 2004, Vol 106, Num 5, pp 449-450, issn 0143-5221, 8 p.Article

Higher Cord C-Peptide Concentrations Are Associated With Slower Growth Rate in the 1st Year of Life in Girls but Not in BoysREGNAULT, Nolwenn; BOTTON, Jeremie; HEUDE, Barbara et al.Diabetes (New York, NY). 2011, Vol 60, Num 8, pp 2152-2159, issn 0012-1797, 8 p.Article

Interaction of CheY with the C-Terminal Peptide of CheZGUHANIYOGI, Jayita; TI WU; PATEL, Smita S et al.Journal of bacteriology. 2008, Vol 190, Num 4, pp 1419-1428, issn 0021-9193, 10 p.Article

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications TrialLACHIN, John M; MCGEE, Paula; PALMER, Jerry P et al.Diabetes (New York, NY). 2014, Vol 63, Num 2, pp 739-748, issn 0012-1797, 10 p.Article

C-peptide immunochemiluminometric assay developed from two seemingly identical polyclonal antiseraKAO, P. C; TAYLOR, R. L; HESER, D. W et al.Annals of clinical and laboratory science. 1992, Vol 22, Num 5, pp 307-316, issn 0091-7370Article

Incorporation of aerobic oxygen into the hydroxyglycyl intermediate during formation of C-terminal peptide amines by peptidylglycine α-amidating monooxygenase (PAM)ZABRISKIE, T. M; HENGMIAO CHENG; VEDERAS, J. C et al.Journal of the Chemical Society. Chemical communications. 1991, Num 8, pp 571-572, issn 0022-4936Article

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protégé TrialHAGOPIAN, William; FERRY, Robert J; LUDVIGSSON, Johnny et al.Diabetes (New York, NY). 2013, Vol 62, Num 11, pp 3901-3908, issn 0012-1797, 8 p.Article

Effects of naloxone on immunoreactive insulin and C-peptide response to intravenous glucagon in obese womenLUNETTA, M; DI MAURO, M; NICOLETTI, F et al.Medical science research. 1993, Vol 21, Num 5, pp 211-212, issn 0269-8951Article

Monoclonal antibodies against the C-terminal peptide of human tissue factor for studies of the cytoplasmic domainCARSON, S. D; YODER, S. C.Blood coagulation & fibrinolysis. 1992, Vol 3, Num 6, pp 779-787, issn 0957-5235Conference Paper

The amino-terminal 29- and 72-Kd fragments of fibronectin mediate selective monocyte recruitementLOHR, K. M; KURTH, C. A; DONG-LIN XIE et al.Blood. 1990, Vol 76, Num 10, pp 2117-2124, issn 0006-4971Article

C-peptide kinetics following an intravenous glucose load in children undergoing regular hemdialysisBULLA, M; RONDA-VILDOSOLA, T; HÜBINGER, D et al.International journal of pediatrics nephrology. 1987, Vol 8, Num 3, pp 159-166, issn 0391-6510Article

Homogeneous Insulin and C-Peptide Sensors for Rapid Assessment of Insulin and C-Peptide Secretion by the IsletsHEYDUK, Ewa; MOXLEY, Michael M; SALVATORI, Alison et al.Diabetes (New York, NY). 2010, Vol 59, Num 10, pp 2360-2365, issn 0012-1797, 6 p.Article

C-Terminal sequencing method for peptides and proteins by the reaction with a vapor of perfluoric acid in acetic anhydrideMIYAZAKI, Kenji; TSUGITA, Akira.Proteomics (Weinheim. Print). 2004, Vol 4, Num 1, pp 11-19, issn 1615-9853, 9 p.Article

La medición del péptido C en los pacientes con diabetes mellitus (DM) Tipo II : su posible utilidad en la decisión de terapia insulínicaTAMEZ-PEREZ, H. E; GARCIA-VALLEJO, C; SANTOS-FLORES, R et al.Archivos de investigación medica. 1990, Vol 21, Num 2, pp 123-126, issn 0066-6769Article

The Clinical Potential of C-Peptide Replacement in Type 1 DiabetesWAHREN, John; KALLAS, Asa; SIMA, Anders A. F et al.Diabetes (New York, NY). 2012, Vol 61, Num 4, pp 761-772, issn 0012-1797, 12 p.Article

Effects of C-peptide on expression of eNOS and iNOS in human cavernosal smooth muscle cellsHAIKUN LI; LIPING XU; DUNBAR, Joseph C et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 3, pp 622-627, issn 0090-4295, 6 p.Article

Acute C-peptide, insulin and branched chain amino acid response to feeding in formula and breast fed infantsWALLENSTEEN, M; LINDBLAD, B. S; ZETTERSTRÖM, R et al.Acta paediatrica scandinavica. 1991, Vol 80, Num 2, pp 143-148, issn 0001-656XArticle

A numerical deconvolution method to estimate C-peptide secretion in humans after an intravenous glucose tolerance testBOSTON, Ray C; PEI, Dee; MOATE, Peter J et al.Metabolism, clinical and experimental. 2009, Vol 58, Num 7, pp 891-900, issn 0026-0495, 10 p.Article

Carassius auratus-Originated Recombinant Histone HI C-Terminal Peptide as Gene Delivery Material : Integration of biological design principles from molecules to cellsHEE JUNG JUNG; DONG SOO HWANG; QUAN DE WEI et al.Biotechnology progress. 2008, Vol 24, Num 1, pp 17-22, issn 8756-7938, 6 p.Conference Paper

Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM)TEPYON CHA; TAHARA, Y; IKEGAMI, H et al.Diabetes research and clinical practice. 1991, Vol 13, Num 3, pp 181-187, issn 0168-8227Article

Angiotensin I converting enzyme and the changes in our concepts through the years : Lewis K. Dahl memorial lectureERDOÊS, E. G.Hypertension (Dallas, Tex. 1979). 1990, Vol 16, Num 4, pp 363-370, issn 0194-911X, 8 p.Conference Paper

Antigenicity and immunogenicity of the C-terminal peptide of human thyroglobulinRABII AMEZIANE EL HASSANI; ESTIENNE, Valérie; BLANCHIN, Stéphanie et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 6, pp 1021-1029, issn 0196-9781, 9 p.Article

Conformational state and receptor recognition of the C-terminal domain of human α 2-macroglobulin after dissociation into half-moleculesJENSEN, Poul Erik H; GUNNARSSON, Martin; STIGBRAND, Torgny et al.Clinica chimica acta. 2001, Vol 310, Num 2, pp 157-163, issn 0009-8981Article

Renal metabolism of C peptide in patients with early insulin-dependent diabetes mellitusZAVARONI, I; ROBAUDO, C; GNUDI, L et al.Frontiers in diabetes. 1990, Vol 10, pp 145-147, issn 0251-5342, 3 p.Article

Le dosage du C-peptide : intérêt en biologie clinique = Interest in biology of the dosage of peptide-CSABOT, O; CHARRIE, A.Lyon pharmaceutique. 1990, Vol 41, Num 4, pp 303-306, issn 0024-7804, 4 p.Article